Quick Answer: Anthropic's 10 November 2026 amended Form S-1 describes a proposed offering of Class A common stock. ANTHROPICUSDT on Phemex is a USDT-margined pre-market perpetual futures contract. A contract position provides price exposure under the exchange's derivatives rules; it does not make its holder a shareholder or deliver Anthropic shares. The filing is preliminary, and an application to list shares is not the same as completed trading on Nasdaq. Check the current contract specifications, order book, and funding terms before acting on the filing.
What did Anthropic file on 10 November?
Anthropic filed Amendment No. 2 to its Form S-1 with the U.S. Securities and Exchange Commission on 10 November 2026. The preliminary prospectus describes a proposed initial public offering of Class A common shares. It states an estimated offering price range of $70 to $78 per share and an application to list on the Nasdaq Global Select Market under the proposed symbol ANT. Those are terms of a proposed securities offering, not evidence that public trading has already begun at any quoted price.
The document itself says that the information is incomplete, may change, and that the securities cannot be sold until the registration statement becomes effective. Later amendments may change the range, share count, timing, or other terms. A reader trying to understand the status of the IPO should use the SEC filing history and the final prospectus, if issued, rather than a social-media post that calls an estimated range a final price.
The range also has a specific unit: dollars per proposed Class A share. It is not automatically a fair value for a perpetual futures position. Even if two markets refer to the same company, they may use different contract units, reference methods, and trading hours. Comparing the two numbers without reading the contract specification can produce a false conclusion about a premium or discount.
What is the ANTHROPICUSDT contract?
Phemex's listing announcement describes ANTHROPICUSDT as a linear, USDT-margined pre-market futures pair. In a perpetual futures contract, the trader posts margin and holds a position whose profit or loss changes with the contract price. The position is an obligation under the derivatives market's rules. It is not a securities account entry showing ownership of Anthropic Class A stock.
The difference is operational as well as legal. A shareholder, after a completed offering and settlement, owns a class of company equity subject to the rights and restrictions in the issuer's documents and applicable securities law. A perpetual trader has a leveraged derivatives position with margin, funding, mark-price, and liquidation rules. The contract can gain or lose value even when no underlying shares are available for public spot trading.
The Phemex announcement links to the ANTHROPICUSDT market page. A reader should inspect that page for the current instrument status and the platform's live contract terms. A historical announcement confirms what the exchange announced at launch; it cannot establish every parameter that applies at the moment of a later trade.
Next step: Review the ANTHROPICUSDT market. Read the current contract details and risk controls before placing an order.
Why might the perpetual price differ from the proposed share price?
A proposed IPO price range is a statement in an offering document. A pre-market perpetual price is formed through bids and offers in a derivatives market. Their units and settlement mechanics must be checked before numerical comparison. Traders may price expected events, uncertainty about the offering, funding costs, and the difficulty of hedging a contract before there is a public share market. These factors can change rapidly and do not create an enforceable promise that the contract will converge to a particular number on a particular date.
Liquidity matters. A small number of orders can produce a visible last trade without providing enough depth for a large position to enter or exit at that price. The bid-ask spread tells a different story from a chart's last-traded number. If a trader submits a market order, execution can cross several price levels. A limit order controls the worst acceptable price but may remain unfilled. Both outcomes matter more than whether an IPO headline is positive or negative.
Phemex's pre-market futures guide says a pre-market derivative may have less order-book depth and no established spot-price anchor. It also describes a change in the reference mechanism when the underlying asset reaches a qualifying spot market. The guide is generic; its terms should not be assumed to forecast the exact treatment of this specific contract. The current announcement and live specification take priority for an instrument-level decision.
How do funding and margin affect the result?
Perpetual futures use periodic funding to connect long and short positioning. Funding is separate from the price change of the contract. A trader can be right about direction and still earn less than expected, or lose money, after funding and trading fees. The direction and amount of a future funding payment can change; a rate shown when the position opens is not a fixed cost for an indefinite holding period.
There is also a document-level issue to check before publication. The ANTHROPICUSDT listing announcement explains how a pre-market premium index is treated, while Phemex's generic pre-market help page gives a general funding schedule. These texts should not be combined into a universal numeric rate for ANTHROPICUSDT. The article should refer readers to the live rate and instrument rules, and an editor should resolve any difference between current product documentation and older help text.
Margin changes the scale of outcomes. A 5% move in a contract price is not a 5% change in the trader's posted margin when leverage is used. Fees, funding, and liquidation rules can further change the result. Liquidation may occur before a later price recovery. Using leverage to express an IPO view therefore adds a timing risk that an unleveraged share investor would experience differently. None of the filing's proposed share terms removes this derivatives risk.
Does the SEC filing settle the question of an IPO date?
No. Filing an S-1 amendment is one step in the securities registration process. The document says the proposed sale would begin after the registration statement becomes effective. It does not, by itself, establish an effective date, final price, first trading day, or that a specific derivatives contract will convert or settle in a specific way. Any article written on 11 November should describe the filing as preliminary and carry an as-of date.
This matters because a headline can be accurate in its narrow sense and misleading in its implication. “Anthropic files amended IPO prospectus” describes a verifiable event. “Anthropic stock now trades at the pre-market perpetual price” would merge two instruments and two price-formation processes. The latter would require evidence that the share market had opened and that the price units were comparable; the filing does not provide that evidence.
An investor seeking actual shares must wait for an available, lawful route to those shares, if the offering proceeds. A Phemex futures position is a different route to market exposure and is subject to the platform's eligibility rules. Neither route should be described as a guaranteed way to profit from a listing.
A five-point checklist before reading the next IPO headline
First, confirm the filing status in SEC EDGAR. Is the document a preliminary amendment or a final prospectus? Record its date and accession number.
Second, identify the instrument named in the headline. A share, a token, and a perpetual contract can all be discussed under the same company name while creating different rights. Ask what exactly is delivered or settled.
Third, compare prices only after checking units and reference methods. A price per Class A share is not automatically a price per derivative contract. A chart without a unit can obscure this distinction.
Fourth, examine market quality: bid, ask, depth, recent trades, and any gap between last and mark price. These are observable inputs to execution and margin decisions. A large quoted move on thin trading may be hard to realize at the displayed price.
Fifth, calculate a position's possible loss using the live funding interval, fees, leverage, and liquidation threshold. Consider whether an event delay, filing revision, or change in liquidity could keep the position open longer than planned. The potential to lose posted margin should be stated plainly beside any discussion of potential upside.
FAQ
Does ANTHROPICUSDT give voting rights or dividends?
No. The Phemex instrument is described as a USDT-margined futures contract. Holding it is not holding Anthropic Class A stock. Any shareholder rights described in the prospectus attach to shares under the relevant terms, not to a crypto derivatives position.
Is the $70–$78 range the final IPO price?
No. The 10 November prospectus identifies it as an estimated range in a preliminary filing. A final price, if the offering proceeds, must be established through later offering documents and the completed pricing process.
Can the perpetual be liquidated before an IPO?
Yes. The contract trades under margin rules independently of the final IPO timetable. An adverse move, changing margin requirements, or other contract-specific conditions may cause a position to be reduced or liquidated. Check the live rules before opening a position.
Does a filed S-1 mean the stock is already listed?
No. The filing describes an application to list the proposed Class A shares. Listing and public trading require additional steps. The SEC filing should be read as a dated status report, not as proof of completed market access.
